• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎基因4型患者纤维化进展率的预测:肝硬化风险评分和宿主因素的作用

Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.

作者信息

Besheer Tarek, El-Bendary Mahmoud, Elalfy Hatem, Abd El-Maksoud Mohamed, Salah Mohamed, Zalata Khaled, Elkashef Wagdi, Elshahawy Heba, Raafat Doaa, Elemshaty Wafaa, Almashad Noha, Zaghloul Hosam, El-Gilany Abdel-Hady, Abdel Razek Ahmed Abdel Khalek, Abd Elwahab Mohamed

机构信息

1 Department of Tropical Medicine, Mansoura University , Mansoura, Egypt .

2 Department of Pathlogy, Mansoura University , Mansoura, Egypt .

出版信息

J Interferon Cytokine Res. 2017 Mar;37(3):97-102. doi: 10.1089/jir.2016.0111. Epub 2017 Jan 9.

DOI:10.1089/jir.2016.0111
PMID:28068153
Abstract

The rate of liver fibrosis progression in chronic hepatitis C (CHC) patients is highly variable and affected by different factors. This study aimed to assess the role of cirrhosis risk score (CRS) based on 7 genetic variants (7 single-nucleotide polymorphisms [SNPs]) and host factors (age and sex) in the prediction of the rate of fibrosis progression in CHC. Duration of infection was determined in 115 patients. The fibrosis progression rate (FPR) per year was calculated as the ratio between fibrosis stage and the duration of infection. SNP genotyping were performed and CRS was determined based on it. FPR was significantly elevated in patients who acquired infection at age >40 years versus those who acquired infection at 30-40 years and those who acquired infection at <30 years. Median FPR was significantly higher in males than females (0.17 vs. 0.15) with P = 0.001. CRS value ≥0.8 is predictive of patients with high risk for cirrhosis, and CRS value <0.5 is predictive of patients with low risk for cirrhosis. There was significant positive correlation between CRS and FPR (P ≤ 0.001). CRS based on 7 SNPs at cutoff value ≥0.8, age at infection >40 years, and male sex are predictors of higher FPR.

摘要

慢性丙型肝炎(CHC)患者的肝纤维化进展速率高度可变,且受不同因素影响。本研究旨在评估基于7种基因变异(7个单核苷酸多态性[SNPs])和宿主因素(年龄和性别)的肝硬化风险评分(CRS)在预测CHC患者肝纤维化进展速率中的作用。对115例患者的感染持续时间进行了测定。每年的纤维化进展速率(FPR)计算为纤维化分期与感染持续时间的比值。进行了SNP基因分型,并据此确定了CRS。与30 - 40岁感染患者及<30岁感染患者相比,>40岁感染患者的FPR显著升高。男性的中位FPR显著高于女性(0.17对0.15),P = 0.001。CRS值≥0.8可预测肝硬化高风险患者,CRS值<0.5可预测肝硬化低风险患者。CRS与FPR之间存在显著正相关(P≤0.001)。基于7个SNP的CRS在临界值≥0.8、感染时年龄>40岁以及男性是较高FPR的预测因素。

相似文献

1
Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.慢性丙型肝炎基因4型患者纤维化进展率的预测:肝硬化风险评分和宿主因素的作用
J Interferon Cytokine Res. 2017 Mar;37(3):97-102. doi: 10.1089/jir.2016.0111. Epub 2017 Jan 9.
2
Impact of common risk factors of fibrosis progression in chronic hepatitis C.慢性丙型肝炎纤维化进展的常见危险因素的影响。
Gut. 2015 Oct;64(10):1605-15. doi: 10.1136/gutjnl-2014-306997. Epub 2014 Sep 11.
3
Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.印度慢性丙型肝炎病毒感染中肝纤维化进展的自然史
J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.
4
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.一种七基因特征(肝硬化风险评分)可预测初发轻度慢性丙型肝炎患者的肝纤维化进展。
Hepatology. 2009 Oct;50(4):1038-44. doi: 10.1002/hep.23111.
5
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.肝硬化风险评分在丙型肝炎患者最小肝病中的纤维化进展早期预测中的作用。
J Hepatol. 2011 Jul;55(1):38-44. doi: 10.1016/j.jhep.2010.10.018. Epub 2010 Nov 23.
6
Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.慢性丙型肝炎基因4型患者肝硬化的诊断:ABCB11基因多态性和血浆胆汁酸水平的作用
Turk J Gastroenterol. 2018 May;29(3):299-307. doi: 10.5152/tjg.2018.17570.
7
The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.PAPAS指数:一种预测丙型肝炎相关纤维化的新型指数。
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):895-900. doi: 10.1097/MEG.0000000000000379.
8
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.在埃及慢性丙型肝炎(4型基因型)慢性血液透析患者中通过FibroScan评估肝纤维化:一项单中心研究。
Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):764-773.
9
Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?平均血小板体积、红细胞分布宽度与血小板计数比值、球蛋白血小板指数以及其他16种间接非侵入性纤维化评分:常规血液检查对慢性丙型肝炎肝纤维化的诊断价值有多大?
J Clin Gastroenterol. 2016 Jul;50(6):518-23. doi: 10.1097/MCG.0000000000000489.
10
[Is APRI score a suitable tool for prediction of fibrosis in Tunisian patients with genotype 1 chronic viral hepatitis C?].[APRI评分是否是预测突尼斯1型慢性丙型病毒性肝炎患者纤维化的合适工具?]
Tunis Med. 2012 Apr;90(4):282-5.

引用本文的文献

1
Integrated neural network and evolutionary algorithm approach for liver fibrosis staging: Can artificial intelligence reduce patient costs?用于肝纤维化分期的集成神经网络和进化算法方法:人工智能能否降低患者成本?
JGH Open. 2024 May 9;8(5):e13075. doi: 10.1002/jgh3.13075. eCollection 2024 May.
2
Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients.S100A4 和 Glypican-3 在丙型肝炎病毒相关肝硬化肝细胞癌中的预后价值。
J Egypt Natl Canc Inst. 2023 Aug 21;35(1):26. doi: 10.1186/s43046-023-00184-1.
3
Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients.
七基因特征研究直接抗病毒药物对丙型肝炎病毒感染患者肝细胞癌发生的影响。
Heliyon. 2022 Aug 8;8(8):e10119. doi: 10.1016/j.heliyon.2022.e10119. eCollection 2022 Aug.
4
Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome.维生素 D 基因多态性与 HCV 感染结局的关联。
Br J Biomed Sci. 2022 Mar 23;79:10237. doi: 10.3389/bjbs.2021.10237. eCollection 2022.
5
Diagnosing the Stage of Hepatitis C Using Machine Learning.利用机器学习诊断丙型肝炎的阶段。
J Healthc Eng. 2021 Dec 10;2021:8062410. doi: 10.1155/2021/8062410. eCollection 2021.
6
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.非乙型肝炎病毒和非丙型肝炎病毒相关性肝细胞癌发病率的增加:单机构 20 年研究。
BMC Gastroenterol. 2021 Jul 31;21(1):306. doi: 10.1186/s12876-021-01884-5.
7
Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients.慢性乙型肝炎患者的肝微环境是纤维化的基础。
World J Gastroenterol. 2020 Jul 21;26(27):3917-3928. doi: 10.3748/wjg.v26.i27.3917.
8
Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation.原位肝移植后Toll样受体与感染之间的相互关系。
World J Transplant. 2020 Jun 29;10(6):162-172. doi: 10.5500/wjt.v10.i6.162.
9
Cardiac health in patients with hepatitis B virus-related cirrhosis.乙型肝炎病毒相关性肝硬化患者的心脏健康
Medicine (Baltimore). 2019 Mar;98(13):e14961. doi: 10.1097/MD.0000000000014961.
10
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.扩散加权磁共振成像及微小RNA在丙型肝炎病毒慢性感染肝纤维化诊断中的应用
World J Gastroenterol. 2019 Mar 21;25(11):1366-1377. doi: 10.3748/wjg.v25.i11.1366.